688098 Shanghai Shen Lian Biomedical Corporation
- 5.02
- -0.26-4.92%
Shanghai Shen Lian Biomedical Corporation News
Announcement of the progress of Shenlian Biopharmaceuticals (Shanghai) Co., Ltd. on the repurchase of the company\'s shares through centralized bidding transactions
Announcement on the first repurchase of company shares through centralized bidding
Announcement on the progress of the repurchase of company shares through centralized bidding transactions
Repurchase Report of Shenlian Biopharmaceuticals (Shanghai) Co., Ltd. on the repurchase of the company\'s shares through centralized bidding transactions
Announcement on the shareholding status of the top ten shareholders and the top ten shareholders with unlimited sale conditions in the share repurchase event
Notice on the plan to repurchase the company\'s shares through centralized bidding
Announcement on the proposal of one of the actual controllers of the company and the chairman to repurchase the company\'s shares
Announcement of Annual Equity Distribution Implementation in 2023
Announcement on the 2023 Profit Distribution Plan
Legal Opinion of Mr. Guo Hao (Shanghai) Office on the abolition of some restricted stocks in the 2019 Restricted Stock Incentive Plan of Shenlian Biopharmaceuticals (Shanghai) Co., Ltd.
Expiry of shareholders\' holdings reduction plan and announcement of holdings reduction results
Announcement on shareholders\' holdings of more than half of the number of shares held and the progress of the reduction
Simplified Statement of Changes in Equity
Announcement on changes in shareholders\' rights and apologies
2022 Annual Equity Distribution Implementation Notice
Prompt announcement on changes in shareholders\' equity
Simplified Statement of Changes in Equity
Announcement of plans for shareholders holding 5% or more of the shares to reduce their holdings
Legal opinion of Guohao Law Firm (Shanghai) on the annulment of some restricted stocks in the 2019 restricted stock incentive plan of Shenlian Biomedical (Shanghai) Co., Ltd.
Announcement on the 2022 profit distribution plan
No Data
